The upsurge in SOD observed in both the tumor tissue and serum of many cancer patients, including sufferers of malignant melanoma [47], some brain tumor, myoma [48], colorectal [42] and lung cancers [49,50], and malignant pleural mesotheliomas [51,52]. This evidence concerns the gene SOD1 and neoplasm.